ResearcherAmsterdam University Medical CentersActive in the last 2 years
Nick van Es
Matched on ORCID iD 0000-0001-5256-6346; OpenAlex author ID A5063712891. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 6
- Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey. Co-author DOI 10.1002/cam4.72306↗
- Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial. Co-author DOI 10.1200/jco-25-01935↗
- Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. Co-author DOI 10.1016/j.thromres.2024.109240↗
- Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. Co-author DOI 10.1016/j.jtha.2023.06.009↗
- Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care. Co-author DOI 10.3390/cancers15143546↗
- The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. Co-author DOI 10.1016/j.thromres.2016.12.013↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Johanna W. Wilmink · 3 shared papers, 2017–2026 · strength 0.51
- Paper Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey. DOI 10.1002/cam4.72306↗
- Paper Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care. DOI 10.3390/cancers15143546↗
- Paper The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. DOI 10.1016/j.thromres.2016.12.013↗
- Ruth A.L. Willems · 2 shared papers, 2023–2026 · strength 0.42
- Hugo Ten Cate · 2 shared papers, 2023–2026 · strength 0.42
- Merlijn U.J.E. Graus · 2 shared papers, 2023–2026 · strength 0.42
- Judith de Vos‐Geelen · 2 shared papers, 2023–2026 · strength 0.42
- Hanneke W. Wilmink · 2 shared papers, 2023–2025 · strength 0.34
- Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
- Paper Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. DOI 10.1016/j.jtha.2023.06.009↗
- Floris T.M. Bosch · 2 shared papers, 2023–2025 · strength 0.34
- Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
- Paper Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. DOI 10.1016/j.jtha.2023.06.009↗
- J. Sven D. Mieog · 2 shared papers, 2023–2025 · strength 0.34
- Hanneke W.M. van Laarhoven · 1 shared paper, 2026 · strength 0.26
- Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.26
- Marjolein Y.V. Homs · 1 shared paper, 2026 · strength 0.26
- Harry Roger Buller · 2 shared papers, 2017–2023 · strength 0.24
- Jeroen T. Buijs · 1 shared paper, 2025 · strength 0.19
- Izaak Quintus Molenaar · 1 shared paper, 2025 · strength 0.19
- Jesse V. Groen · 1 shared paper, 2025 · strength 0.19
- Randa G. Hanna-Sawires · 1 shared paper, 2025 · strength 0.19
- Joanne Verheij · 1 shared paper, 2025 · strength 0.19
- Frederike Dijk · 1 shared paper, 2025 · strength 0.19
- Bert A. Bonsing · 1 shared paper, 2025 · strength 0.19
- Marc G. Besselink · 1 shared paper, 2025 · strength 0.19
- Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.19
- Maarten F. Bijlsma · 1 shared paper, 2025 · strength 0.19
- Elena Campello · 1 shared paper, 2023 · strength 0.15
- Antonio Pea · 1 shared paper, 2023 · strength 0.15
- Paolo Simioni · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.